CXCL12 and glioma: Furthermore, Du et al. demonstrated that intracranial implants of HIF1-deficient glioma cells had reduced levels of infiltrating monocytes within tumors as well as reduced levels of tumor SDF-1 and MMP-9 protein expression (Du et al., 2008).